Lionel Mignion

10PUBLICATIONS
41CO-AUTHORS
Ship and platform structures (incl. maritime hydrodynamics)Molecular targetsRadiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 20, 2026
A dual-modal <sup>19</sup>F MRI/<sup>18</sup>F PET approach using sultone-derived chemical tags.

Amaury Guillou, Nicolas Joudiou, Alice Fortin

|Jan 31, 2025
PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma.

Valentin Van den Bossche, Julie Vignau, Engy Vigneron

|Dec 27, 2024
Mitochondria-targeted antioxidant MitoQ radiosensitizes tumors by decreasing mitochondrial oxygen consumption.

Justin D Rondeau, Sara Lipari, Barbara Mathieu

|Feb 10, 2024
Metabolic Profiling to Assess Response to Targeted and Immune Therapy in Melanoma.

Chantale Farah, Lionel Mignion, Bénédicte F Jordan

|May 05, 2023
Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression.

Veronica Finisguerra, Tereza Dvorakova, Matteo Formenti

|Feb 11, 2023
Hyperpolarized <sup>13</sup>C-Pyruvate to Assess Response to Anti-PD1 Immune Checkpoint Inhibition in YUMMER 1.7 Melanoma Xenografts.

Chantale Farah, Marie-Aline Neveu, Caroline Bouzin

Pageof 2